Key result
Aorto-mesenteric bypass resolves recurrent mesenteric ischemia following failed retrograde open mesenteric stenting.
Why the study?
Chronic mesenteric ischemia is a rare condition with often delayed diagnosis due to nonspecific symptoms, and first-line endovascular treatment may be limited by restenosis or intrastent thrombosis, requiring open surgery.
Case Report (n=1)
No
This case illustrates that while retrograde open mesenteric stenting (ROMS) is a viable initial hybrid strategy for acute-on-chronic mesenteric ischemia with bowel necrosis and a contaminated field, late covered stent thrombosis can occur, making open aorto-mesenteric bypass an essential surgical salvage option.
Answers are grounded in this paper and cite their sources.
Open bypass may salvage symptoms after mesenteric stent thrombosis; leaves open comparative trials for optimal sequencing.
INTRODUCTION: Chronic mesenteric ischemia (CMI) is a rare pathology, most commonly associated with multivessel atherosclerosis, whose diagnosis is often delayed due to nonspecific symptoms. Endovascular treatment is the first-line treatment option, although its results may be limited by restenosis or intrastent thrombosis. Open surgery remains an important option in cases where endoluminal treatment has failed. The aim of this paper is to illustrate, through a clinical case, the diagnostic and therapeutic challenges associated with severe CMI.
No takes yet. Share an insight, caveat, or question.
Kaddouri et al. (2026) conducted a case report in Acute-on-chronic mesenteric ischemia (n=1). Retrograde open mesenteric stenting (ROMS) followed by salvage aorto-mesenteric bypass was evaluated on Resolution of mesenteric ischemia symptoms and stent/graft patency. Aorto-mesenteric bypass resolved recurrent abdominal pain and improved nutritional status in a 69-year-old woman after retrograde open mesenteric stenting failed due to thrombosis at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: